2012
DOI: 10.1007/s11051-012-1218-5
|View full text |Cite
|
Sign up to set email alerts
|

Novel ZnO-binding peptides obtained by the screening of a phage display peptide library

Abstract: Zinc oxide (ZnO) is a semiconductor compound with a potential for wide use in various applications, including biomaterials and biosensors, particularly as nanoparticles (the size range of ZnO nanoparticles is from 2 to 100 nm, with an average of about 35 nm). Here, we report isolation of novel ZnO-binding peptides, by screening of a phage display library. Interestingly, amino acid sequences of the ZnO-binding peptides reported in this paper and those described previously are significantly different. This sugge… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
21
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 25 publications
(22 citation statements)
references
References 25 publications
1
21
0
Order By: Relevance
“…These are possible conditions required for the storage of this formulated loaded ΦKAZ14 bacteriophage product to remain viable. Consistent with this finding, Golec et al [23] have demonstrated that tailed phages could be stored inside infected cells at −80 °C without a major loss of phage and host viability, which may seem a similar scenario to encapsulation of ΦKAZ14 bacteriophage in CS-NPs where it remained protected and maintained its viability under similar storage conditions. Similarly, Escherichia coli bacteriophage T4 (ATCC ® 11303-B41™, Manassas, VA, USA).…”
Section: Discussionsupporting
confidence: 57%
“…These are possible conditions required for the storage of this formulated loaded ΦKAZ14 bacteriophage product to remain viable. Consistent with this finding, Golec et al [23] have demonstrated that tailed phages could be stored inside infected cells at −80 °C without a major loss of phage and host viability, which may seem a similar scenario to encapsulation of ΦKAZ14 bacteriophage in CS-NPs where it remained protected and maintained its viability under similar storage conditions. Similarly, Escherichia coli bacteriophage T4 (ATCC ® 11303-B41™, Manassas, VA, USA).…”
Section: Discussionsupporting
confidence: 57%
“…Their antibacterial properties are used in phage therapy – against antibiotic‐resistant bacteria in humans (Takemura‐Uchiyama et al ., ) and animals (Kropinski et al ., ), to combat bacterial infections in fungi and plants (Adriaenssens et al ., ; Sajben‐Nagy et al ., ), and in food industry as antibacterial components of forage (García et al ., ). Furthermore, phages are used in phage display technique (Sidhu, ; Golec et al ., ) and as potential therapeutic gene‐delivery vehicles or as vehicles for the delivery of vaccines (Clark & March, ; Tao et al ., ). On the other hand, their antibacterial properties cause substantial financial losses in the biofermentation industry (Marcó et al ., ).…”
Section: Introductionmentioning
confidence: 99%
“…Herein, we designed a novel β-annulus peptide connected via a ZnO-binding sequence at the N -terminal, which is directed toward the interior of the peptide nanocapsules. To date, several ZnO-binding peptides have been developed by the screening of peptide libraries [ 50 , 51 , 52 , 53 ]. We employed the HCVAHR sequence, developed by Okochi et al [ 54 ], as the ZnO-binding peptide, because this short peptide exhibits the highest affinity toward ZnO among the reported ZnO-binding peptides [ 55 ].…”
Section: Introductionmentioning
confidence: 99%